These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2930626)

  • 41. Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture.
    Carlin SC; Rosenberg RN; VandeVenter L; Friedkin M
    Mol Pharmacol; 1974 Mar; 10(2):194-203. PubMed ID: 4546895
    [No Abstract]   [Full Text] [Related]  

  • 42. Estimation of the in vitro and in vivo inhibitory effects of antifolates upon thymidylate synthase (TS) in whole cells.
    Taylor GA; Jackman AL; Balmanno K; Hughes LR; Calvert AH
    Adv Exp Med Biol; 1989; 253B():383-8. PubMed ID: 2610126
    [No Abstract]   [Full Text] [Related]  

  • 43. Synthesis and antifolate evaluation of the 10-propargyl derivatives of 5-deazafolic acid, 5-deazaaminopterin, and 5-methyl-5-deazaaminopterin.
    Piper JR; Malik ND; Rhee MS; Galivan J; Sirotnak FM
    J Med Chem; 1992 Jan; 35(2):332-7. PubMed ID: 1732551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antifolate drug interactions: enhancement of growth inhibition due to the antipurine 5,10-dideazatetrahydrofolic acid by the lipophilic dihydrofolate reductase inhibitors metoprine and trimetrexate.
    Galivan J; Nimec Z; Rhee M; Boschelli D; Oronsky AL; Kerwar SS
    Cancer Res; 1988 May; 48(9):2421-5. PubMed ID: 2965613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
    Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
    Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Folate analogues. 21. Synthesis and antifolate and antitumor activities of N10-(cyanomethyl)-5,8-dideazafolic acid.
    Nair MG; Salter DC; Kisliuk RL; Gaumont Y; North G; Sirotnak FM
    J Med Chem; 1983 Apr; 26(4):605-7. PubMed ID: 6403710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse.
    Newell DR; Alison DL; Calvert AH; Harrap KR; Jarman M; Jones TR; Manteuffel-Cymborowska M; O'Connor P
    Cancer Treat Rep; 1986 Aug; 70(8):971-9. PubMed ID: 3731153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
    Fisher TC; Milner AE; Gregory CD; Jackman AL; Aherne GW; Hartley JA; Dive C; Hickman JA
    Cancer Res; 1993 Jul; 53(14):3321-6. PubMed ID: 8324744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.
    Fernandes DJ; Bertino JR; Hynes JB
    Cancer Res; 1983 Mar; 43(3):1117-23. PubMed ID: 6825083
    [No Abstract]   [Full Text] [Related]  

  • 50. The synthesis and thymidylate synthase inhibitory activity of L-gamma-L-linked dipeptide and L-gamma-amide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Bisset GM; Bavetsias V; Thornton TJ; Pawelczak K; Calvert AH; Hughes LR; Jackman AL
    J Med Chem; 1994 Sep; 37(20):3294-302. PubMed ID: 7932557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.
    Calvert AH; Alison DL; Harland SJ; Robinson BA; Jackman AL; Jones TR; Newell DR; Siddik ZH; Wiltshaw E; McElwain TJ
    J Clin Oncol; 1986 Aug; 4(8):1245-52. PubMed ID: 3734849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gamma-linked dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8- dideazafolate as antitumour agents.
    Jackman AL; Bisset GM; Jodrell DI; Gibson W; Kimbell R; Bavetsias V; Calvert AH; Harrap KR; Stephens TC; Smith MN
    Adv Exp Med Biol; 1993; 338():579-84. PubMed ID: 8304184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice.
    Jones TR; Calvert AH; Jackman AL; Brown SJ; Jones M; Harrap KR
    Eur J Cancer (1965); 1981 Jan; 17(1):11-9. PubMed ID: 7262141
    [No Abstract]   [Full Text] [Related]  

  • 54. Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.
    Jones TR; Webber SE; Varney MD; Reddy MR; Lewis KK; Kathardekar V; Mazdiyasni H; Deal J; Nguyen D; Welsh KM; Webber S; Johnston A; Matthews DA; Smith WW; Janson CA; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Bartlett CA; Morse CA
    J Med Chem; 1997 Feb; 40(5):677-83. PubMed ID: 9057854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthase.
    Ward WH; Kimbell R; Jackman AL
    Biochem Pharmacol; 1992 May; 43(9):2029-31. PubMed ID: 1596289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The 3D-QSAR analysis of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains on thymidylate synthase.
    Liu S; Liu F; Yu X; Ding G; Xu P; Cao J; Jiang Y
    Bioorg Med Chem; 2006 Mar; 14(5):1425-30. PubMed ID: 16263296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclopenta[g]quinazoline-based antifolates: the effect of the chirality at the 6-position on the inhibition of thymidylate synthase (TS).
    Bavetsias V; Marriott JH; Theti DS; Melin JC; Wilson SC; Jackman AL
    Bioorg Med Chem Lett; 2001 Dec; 11(23):3015-7. PubMed ID: 11714600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase.
    Duch DS; Banks S; Dev IK; Dickerson SH; Ferone R; Heath LS; Humphreys J; Knick V; Pendergast W; Singer S
    Cancer Res; 1993 Feb; 53(4):810-8. PubMed ID: 8428362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formation and retention and biological activity of N10-propargyl-5,8-dideazafolic acid (CB3717) polyglutamates in L1210 cells in vitro.
    Sikora E; Jackman AL; Newell DR; Calvert AH
    Biochem Pharmacol; 1988 Nov; 37(21):4047-54. PubMed ID: 2461200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.